Valuation: Vitrolife AB

Market Cap 12.36B 1.3B 1.12B 1.04B 955M 1.8B 125B 1.82B 4.81B 62.66B 4.89B 4.79B 207B P/E 2026 *
25.1x
P/E 2027 * 20.3x
Enterprise Value 12.91B 1.36B 1.17B 1.09B 998M 1.88B 130B 1.9B 5.02B 65.45B 5.11B 5B 217B EV / Sales 2026 *
3.73x
EV / Sales 2027 * 3.33x
Free-Float
54.39%
Yield 2026 *
1.21%
Yield 2027 * 1.38%
1 day+1.10%
1 week+3.01%
Current month+7.20%
1 month+7.95%
3 months-11.59%
6 months+1.93%
Current year-32.63%
1 week 88.65
Extreme 88.65
92.6
1 month 84
Extreme 84
93.9
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
2/6/26 A Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 A Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 A Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%+3.01%-33.36%-37.17% 1.3B
-4.40%+0.93%+165.77%+333.53% 21.9B
+0.81%+2.81%-40.56%-21.65% 10.21B
-2.03%+10.02%+346.15%+33.81% 8.31B
-0.53%+20.80%-33.51% - 7.38B
+0.83%-0.11%+73.17%+54.48% 6.58B
-0.77%+0.04%-13.96%-5.96% 6.02B
+0.03%+2.41%-12.60%-18.83% 4.36B
-4.85%-11.04%+61.51%+100.45% 4.2B
-1.50%+3.68%-18.74%-25.78% 2.9B
Average -1.13%+2.47%+49.39%+45.87% 7.32B
Weighted average by Cap. -1.79%+3.10%+86.78%+120.15%

Financials

2026 *2027 *
Net sales 3.46B 364M 312M 292M 267M 504M 34.9B 509M 1.34B 17.52B 1.37B 1.34B 57.98B 3.71B 391M 335M 313M 286M 541M 37.42B 546M 1.44B 18.79B 1.47B 1.44B 62.16B
Net income 493M 51.92M 44.49M 41.62M 38.05M 71.81M 4.97B 72.57M 192M 2.5B 195M 191M 8.26B 609M 64.17M 54.99M 51.44M 47.03M 88.75M 6.14B 89.7M 237M 3.09B 241M 236M 10.21B
Net Debt 549M 57.87M 49.6M 46.4M 42.42M 80.05M 5.54B 80.9M 213M 2.78B 217M 213M 9.21B -26.74M -2.82M -2.42M -2.26M -2.07M -3.9M -270M -3.94M -10.4M -136M -10.58M -10.35M -448M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
25/08/26 SEK 92.35 +1.15% 42,572
24/08/26 SEK 91.30 +0.27% 102,970
21/08/26 SEK 91.05 -0.82% 103,764
20/08/26 SEK 91.80 +2.34% 145,505
19/08/26 SEK 89.70 +0.11% 92,786
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
91.30SEK
Average target price
129.60SEK
Spread / Average Target
+41.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock